Tenaya Therapeutics
TNYA
73 hedge funds and large institutions have $102M invested in Tenaya Therapeutics in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 3 closing their positions.
767% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 3
110% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 10
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
46% more funds holding
Funds holding: 50 → 73 (+23)
4.53% less ownership
Funds ownership: 89.72% → 85.19% (-4.5%)
51% less capital invested
Capital invested by funds: $209M → $102M (-$106M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $145K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ROTUOC
Regents of the University of California
Oakland,
California
|
+$7.59M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$786K |
| 4 |
Renaissance Technologies
New York
|
+$776K |
| 5 |
Citigroup
New York
|
+$741K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.2M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$9.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.85M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.72M |
| 5 |
CC
Commodore Capital
New York
|
-$2.01M |
TNYA Hedge Fund Activity: Q3 2022 in Review
73 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q3 2022, worth a combined $102M — down 51% from $209M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new TNYA positions and 3 closed out — a net gain of 23 holders — while 21 added to existing stakes and 10 trimmed.
The largest buyer was Regents of the University of California, opening a new position worth an estimated $7.59M. The largest seller was Fidelity Investments, cutting an estimated $11.2M.
- 73 institutional investors held Tenaya Therapeutics (TNYA) as of Q3 2022, up from 50 in Q2 2022.
- Funds reported $102M of Tenaya Therapeutics stock for Q3 2022, down 51% quarter-over-quarter.
- 26 funds opened new Tenaya Therapeutics positions in Q3 2022 and 3 closed out, a net change of +23 holders.
- The largest Tenaya Therapeutics buyer in Q3 2022 was Regents of the University of California, an estimated $7.59M added.
- The largest Tenaya Therapeutics seller in Q3 2022 was Fidelity Investments, an estimated $11.2M sold.
Based on aggregated 13F filings for Q3 2022.